世界のラロキシフェン塩酸塩市場2022~2026:薬局、化学工業、その他

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR73914-22)
■ 英語タイトル:Global Raloxifene Hydrochloride Market 2022-2026
■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR73914-22
■ 発行日:2022年7月11日
■ 調査対象地域:北米、ヨーロッパ、アジア、その他地域
■ 産業分野:医薬品
■ ページ数:約120
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥332,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥532,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界のラロキシフェン塩酸塩市場2022~2026:薬局、化学工業、その他]についてメールでお問い合わせはこちら
Technavio社発行の当調査レポートでは、世界のラロキシフェン塩酸塩市場規模が2022年から2026年まで年平均7.11%成長し、502.78百万ドルに達すると予測しています。当書は、ラロキシフェン塩酸塩の世界市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、エンドユーザー別(薬局、化学工業、その他)分析、顧客状況、地域別状況、推進要因・課題・動向、企業状況、企業分析などの構成でまとめております。なお、主要企業として、Amneal Pharmaceuticals Inc.、Cadila Pharmaceuticals Ltd.、Camber Pharmaceuticals Inc.、Cipla Ltd.、Dr. Reddys Laboratories Ltd.、Eli Lilly and Co.、Glenmark Pharmaceuticals Ltd.、Jiangsu Hengrui Pharmaceuticals Co. Ltd.などが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界のラロキシフェン塩酸塩市場規模:エンドユーザー別(薬局、化学工業、その他)
・顧客状況
・地域別状況
・推進要因・課題・動向
・企業状況
・企業分析
*** レポート概要(サマリー)***

Global Raloxifene Hydrochloride Market 2022-2026

Technavio has been monitoring the raloxifene hydrochloride market and it is poised to grow by $ 502.78 mn during 2022-2026, accelerating at a CAGR of 7.11% during the forecast period. Our report on the raloxifene hydrochloride market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of osteoporosis driving the market demand, growing application in the chemical industry, and availability of guidelines for disease management.

The raloxifene hydrochloride market analysis includes the end-user segment and geographic landscape.
Technavio’s raloxifene hydrochloride market is segmented as below:

By End-user
• Pharmacy
• Chemical industry
• Others

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the reimbursement programs and coverage of drugs by health insurance as one of the prime reasons driving the raloxifene hydrochloride market growth during the next few years. Also, expanding research activities on the application of raloxifene HCl in rheumatoid arthritis and growing demand from APAC region will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the raloxifene hydrochloride market covers the following areas:
• Raloxifene hydrochloride market sizing
• Raloxifene hydrochloride market forecast
• Raloxifene hydrochloride market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading raloxifene hydrochloride market vendors including Amneal Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Camber Pharmaceuticals Inc., Cipla Ltd., Dr. Reddys Laboratories Ltd., Eli Lilly and Co., Glenmark Pharmaceuticals Ltd., Jiangsu Hengrui Pharmaceuticals Co. Ltd., Sanika Chemical Pvt Ltd., Taj Pharmaceutical Ltd., Teva Pharmaceutical Industries Ltd., and Zydus Lifesciences Ltd. Also, the raloxifene hydrochloride market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/raloxifene-hydrochloride-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

*** レポート目次(コンテンツ)***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by End-user
o 5.1 Market segments
o Exhibit 24: Chart on End-user – Market share 2021-2026 (%)
o Exhibit 25: Data Table on End-user – Market share 2021-2026 (%)
o 5.2 Comparison by End-user
o Exhibit 26: Chart on Comparison by End-user
o Exhibit 27: Data Table on Comparison by End-user
o 5.3 Pharmacy – Market size and forecast 2021-2026
o Exhibit 28: Chart on Pharmacy – Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Pharmacy – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Pharmacy – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Pharmacy – Year-over-year growth 2021-2026 (%)
o 5.4 Chemical industry – Market size and forecast 2021-2026
o Exhibit 32: Chart on Chemical industry – Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Chemical industry – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Chemical industry – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Chemical industry – Year-over-year growth 2021-2026 (%)
o 5.5 Others – Market size and forecast 2021-2026
o Exhibit 36: Chart on Others – Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Others – Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Others – Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Others – Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by End-user
o Exhibit 40: Market opportunity by End-user ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 46: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 Asia – Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 62: Chart on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 China – Market size and forecast 2021-2026
o Exhibit 66: Chart on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on China – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on China – Year-over-year growth 2021-2026 (%)
o 7.9 Germany – Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany – Year-over-year growth 2021-2026 (%)
o 7.10 Canada – Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada – Year-over-year growth 2021-2026 (%)
o 7.11 UK – Market size and forecast 2021-2026
o Exhibit 78: Chart on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on UK – Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on UK – Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Amneal Pharmaceuticals Inc.
o Exhibit 89: Amneal Pharmaceuticals Inc. – Overview
o Exhibit 90: Amneal Pharmaceuticals Inc. – Business segments
o Exhibit 91: Amneal Pharmaceuticals Inc. – Key news
o Exhibit 92: Amneal Pharmaceuticals Inc. – Key offerings
o Exhibit 93: Amneal Pharmaceuticals Inc. – Segment focus
o 10.4 Cadila Pharmaceuticals Ltd.
o Exhibit 94: Cadila Pharmaceuticals Ltd. – Overview
o Exhibit 95: Cadila Pharmaceuticals Ltd. – Business segments
o Exhibit 96: Cadila Pharmaceuticals Ltd. – Key offerings
o Exhibit 97: Cadila Pharmaceuticals Ltd. – Segment focus
o 10.5 Camber Pharmaceuticals Inc.
o Exhibit 98: Camber Pharmaceuticals Inc. – Overview
o Exhibit 99: Camber Pharmaceuticals Inc. – Product / Service
o Exhibit 100: Camber Pharmaceuticals Inc. – Key offerings
o 10.6 Cipla Ltd.
o Exhibit 101: Cipla Ltd. – Overview
o Exhibit 102: Cipla Ltd. – Business segments
o Exhibit 103: Cipla Ltd. – Key news
o Exhibit 104: Cipla Ltd. – Key offerings
o Exhibit 105: Cipla Ltd. – Segment focus
o 10.7 Eli Lilly and Co.
o Exhibit 106: Eli Lilly and Co. – Overview
o Exhibit 107: Eli Lilly and Co. – Product / Service
o Exhibit 108: Eli Lilly and Co. – Key offerings
o 10.8 Jiangsu Hengrui Pharmaceuticals Co. Ltd.
o Exhibit 109: Jiangsu Hengrui Pharmaceuticals Co. Ltd. – Overview
o Exhibit 110: Jiangsu Hengrui Pharmaceuticals Co. Ltd. – Product / Service
o Exhibit 111: Jiangsu Hengrui Pharmaceuticals Co. Ltd. – Key offerings
o 10.9 Sanika Chemical Pvt Ltd.
o Exhibit 112: Sanika Chemical Pvt Ltd. – Overview
o Exhibit 113: Sanika Chemical Pvt Ltd. – Product / Service
o Exhibit 114: Sanika Chemical Pvt Ltd. – Key offerings
o 10.10 Taj Pharmaceutical Ltd.
o Exhibit 115: Taj Pharmaceutical Ltd. – Overview
o Exhibit 116: Taj Pharmaceutical Ltd. – Product / Service
o Exhibit 117: Taj Pharmaceutical Ltd. – Key offerings
o 10.11 Teva Pharmaceutical Industries Ltd.
o Exhibit 118: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 119: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 120: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 121: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 122: Teva Pharmaceutical Industries Ltd. – Segment focus
o 10.12 Zydus Lifesciences Ltd.
o Exhibit 123: Zydus Lifesciences Ltd. – Overview
o Exhibit 124: Zydus Lifesciences Ltd. – Business segments
o Exhibit 125: Zydus Lifesciences Ltd. – Key news
o Exhibit 126: Zydus Lifesciences Ltd. – Key offerings
o Exhibit 127: Zydus Lifesciences Ltd. – Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 128: Inclusions checklist
o Exhibit 129: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 130: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 131: Research methodology
o Exhibit 132: Validation techniques employed for market sizing
o Exhibit 133: Information sources
o 11.5 List of abbreviations
o Exhibit 134: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by End-user
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on End-user – Market share 2021-2026 (%)
Exhibits25: Data Table on End-user – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by End-user
Exhibits27: Data Table on Comparison by End-user
Exhibits28: Chart on Pharmacy – Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Pharmacy – Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Pharmacy – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Pharmacy – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Chemical industry – Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Chemical industry – Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Chemical industry – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Chemical industry – Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Others – Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Others – Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Others – Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Others – Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by End-user ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China – Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China – Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China – Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany – Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada – Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada – Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK – Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on UK – Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on UK – Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK – Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Amneal Pharmaceuticals Inc. – Overview
Exhibits90: Amneal Pharmaceuticals Inc. – Business segments
Exhibits91: Amneal Pharmaceuticals Inc. – Key news
Exhibits92: Amneal Pharmaceuticals Inc. – Key offerings
Exhibits93: Amneal Pharmaceuticals Inc. – Segment focus
Exhibits94: Cadila Pharmaceuticals Ltd. – Overview
Exhibits95: Cadila Pharmaceuticals Ltd. – Business segments
Exhibits96: Cadila Pharmaceuticals Ltd. – Key offerings
Exhibits97: Cadila Pharmaceuticals Ltd. – Segment focus
Exhibits98: Camber Pharmaceuticals Inc. – Overview
Exhibits99: Camber Pharmaceuticals Inc. – Product / Service
Exhibits100: Camber Pharmaceuticals Inc. – Key offerings
Exhibits101: Cipla Ltd. – Overview
Exhibits102: Cipla Ltd. – Business segments
Exhibits103: Cipla Ltd. – Key news
Exhibits104: Cipla Ltd. – Key offerings
Exhibits105: Cipla Ltd. – Segment focus
Exhibits106: Eli Lilly and Co. – Overview
Exhibits107: Eli Lilly and Co. – Product / Service
Exhibits108: Eli Lilly and Co. – Key offerings
Exhibits109: Jiangsu Hengrui Pharmaceuticals Co. Ltd. – Overview
Exhibits110: Jiangsu Hengrui Pharmaceuticals Co. Ltd. – Product / Service
Exhibits111: Jiangsu Hengrui Pharmaceuticals Co. Ltd. – Key offerings
Exhibits112: Sanika Chemical Pvt Ltd. – Overview
Exhibits113: Sanika Chemical Pvt Ltd. – Product / Service
Exhibits114: Sanika Chemical Pvt Ltd. – Key offerings
Exhibits115: Taj Pharmaceutical Ltd. – Overview
Exhibits116: Taj Pharmaceutical Ltd. – Product / Service
Exhibits117: Taj Pharmaceutical Ltd. – Key offerings
Exhibits118: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits119: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits120: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits121: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits122: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits123: Zydus Lifesciences Ltd. – Overview
Exhibits124: Zydus Lifesciences Ltd. – Business segments
Exhibits125: Zydus Lifesciences Ltd. – Key news
Exhibits126: Zydus Lifesciences Ltd. – Key offerings
Exhibits127: Zydus Lifesciences Ltd. – Segment focus
Exhibits128: Inclusions checklist
Exhibits129: Exclusions checklist
Exhibits130: Currency conversion rates for US$
Exhibits131: Research methodology
Exhibits132: Validation techniques employed for market sizing
Exhibits133: Information sources
Exhibits134: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR73914-22 )"世界のラロキシフェン塩酸塩市場2022~2026:薬局、化学工業、その他" (英文:Global Raloxifene Hydrochloride Market 2022-2026)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。